TATA HEALTH (01255) Receives Additional Resumption Guidance from Stock Exchange, Remains Suspended

Stock News
2025/09/05

TATA HEALTH (01255) announced that on September 4, 2025, the company received a letter from the Stock Exchange setting out additional guidance for the resumption of trading of shares on the Stock Exchange (the "Additional Resumption Guidance", which together with the preliminary resumption guidance, are collectively referred to as the "Resumption Guidance"): re-compliance with Rule 3.10(2) of the Listing Rules. Additionally, the company's shares continue to be suspended from trading.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10